Aminooxy Modifier CE-Phosphoramidite
Phosphoramidite for incorporation of an aminooxy-moiety into an oligonucleotide for ligation applications.
Phosphoramidite for incorporation of an aminooxy-moiety into an oligonucleotide for ligation applications.
Half of a novel base pair (with dNaM) that achieves pair recognition through hydrophobic interactions.
Phosphoramidite for incorporation of a 2'-O-methyl modified ribo-G nucleobase within an oligonucleotide
Reagent for phosphorothioate oligonucleotide synthesis. Also known as DDTT.
Phosphoramidite for incorporation of a nucleobase-tethered amine that can be deprotected prior to cleaving the oligonucleotide from the solid support.
CPG column for incorporation of a 2'-O-methyl modified ribo-C nucleobase at the 3' end of an oligonucleotide.
A stable phosphoramidite analogue of N3-methyladenine (3-Me-A).
CPG useful for synthesising 2'-5' linked oligonucleotides, and effecting 3' termination.
Phosphoramidite for incorporation of a 2'-fluoro-modified U nucleobase within an oligonucleotide
Phosphoramidite used to incorporate a 8-oxo-modified deoxyadenosine into an oligonucleotide.
CPG for the incorporation of an amino function at the 3' end of an oligonucleotide.
Phosphoramidite for incorporation of a 2'-O-methyl modified ribo-G nucleobase within an oligonucleotide
Phosphoramidite for the incorporation of an internal amino function into an oligonucleotide.
Phosphoramidite used to incorporate a BlackBerry-650™ II moiety at the 5' end of an oligonucleotide.
Phosphoramidite for the installation of a strained cyclooctyne (BCN) into an oligonucleotide for subsequent copper-free click elaboration.
Phosphoramidite for the installation of a strained cyclooctyne (BCN) into an oligonucleotide for subsequent copper-free click elaboration.
A state-of-the-art cyclooctyne for catalyst free strain-promoted, copper-free azide-alkyne cycloadditions.
A state-of-the-art cyclooctyne for catalyst free strain-promoted, copper-free azide-alkyne cycloadditions.
Phosphoramidite useful for synthesising 2'-5' linked oligonucleotides.
Useful for incorporating 7-Deaza-modified guanosine into oligonucleotides to disrupt unwanted hydrogen bonding.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |